Levulan: profile and news

DUSA Pharmaceuticals Reports Statistically Significant Results ... Feb 24, 2006
The study used DUSA's Levulan(R) (aminolevulinic acid HCl, ALA) Kerastick(R) in combination with either the Company's BLU-U(R) brand blue light ("BLU-U"), an ... - PharmaLive.com (press release),

DUSA Pharmaceuticals Reports Statistically Significant Results ... Feb 24, 2006
The study used DUSA’s Levulan® (aminolevulinic acid HCl, ALA) Kerastick® incombination with either the Company’s BLU-U® brand blue light (“BLU-U ... - PharmaLive.com (press release),

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ... Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick(R) sales of the Company's Levulan(R) photodynamic therapy ... - Genetic Engineering News,

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ... Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick ® sales of the Company's Levulan ® photodynamic therapy ... - CCNMatthews (press release),

Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial ... Feb 1, 2006
...(NASDAQ NMS:DUSA), today reported results from its multi-center Phase II clinical study of photodynamic therapy (PDT) using DUSA's Levulan(R) (aminolevulinic ... - Genetic Engineering News,

Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial ... Feb 1, 2006
The results of the study indicate that both 'Levulan BLU-U' and 'BLU-U alone' appear to effectively reduce the number of both inflammatory and non-inflammatory ... - Business Wire (press release),

BEFORE THE BELL: Intel Slips After Downgrade >INTC -2- Feb 24, 2006
38 cents, or 5.6%, to $7.20 after receiving "statistically significant" interim results from its Phase II study of photodynamic therapy Levulan, which treats ... - Yahoo! News

Dusa shares plunge as acne drug study disappoints Feb 1, 2006
The drug, Levulan, used in combination with Dusa's BLU-U (Blue Light Photodynamic Therapy Illuminator) appeared to be about as effective as BLU-U therapy alone ... - Reuters

DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year ... Feb 1, 2006
...is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple ... - Genetic Engineering News,

Dusa Pharma Shares Plummet on Acne Study Feb 1, 2006
The therapy is designed to be a two-step process that starts with Dusa's Levulan Kerastick solution to prime the skin, making affected areas more sensitive to ... - Houston Chronicle,

Doctors fear acne drug rules go too far Jan 30, 2006
Another acne treatment, Levulan-PDT (for photodynamic therapy), involves using a laser or blue light after coating the face in a cream that makes the skin more ... - Atlanta Journal Constitution (subscription),

DUSA Pharmaceuticals Sues Additional Physicians For Infringement ... Jan 23, 2006
In one of these cases, the defendant physician also admitted to illegally using DUSA's Levulan(R) trademark in connection with his infringing activities and ... - PharmaLive.com (press release),

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ... Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick ® sales of the Company's Levulan ® photodynamic therapy ... - CCNMatthews (press release),

DUSA Pharmaceuticals Announces Exclusive Agreement With Stiefel ... Jan 18, 2006
The agreement covers current and future uses of DUSA's proprietary Levulan(R) Kerastick(R) for photodynamic therapy (PDT) in dermatology. ... - Business Wire (press release),

Advanced Facial Plastic Surgery Center in Dallas Offers ... Jan 9, 2006
...(PRWEB) January 9, 2006 -- The Levulan PDT system is an advanced two-step treatment for minimally to moderately thick AKs. First ... - PR Web (press release),

Clinic offers beautification procedures Jan 16, 2006
...and she performs PhotoFacial Rejuvenation for sun damaged skin and removal of brown spots and reddish blotches, PhotoDynamic Therapy with Levulan for treatment ... - Sarasota Herald-Tribune,

DUSA Pharmaceuticals Sues Physicians For Infringement of its ... Nov 21, 2005
...today it has filed lawsuits against physicians in California, Florida, and Tennessee to prevent their continued use of versions of its Levulan(R) brand of ... - Business Wire (press release),

Cancer treatment also may help heal acne, sun damage, some say Sep 26, 2005
The procedure involves applying a topical solution called 5-aminolevulinic acid (Levulan Kerastick) directly to the skin, then activating it with a light ... - DetNews.com,

Cures and controversy in stopping acne Oct 3, 2005
..."The side effects were an issue," she said about Accutane. During the photodynamic therapy, a medication called Levulan is painted on the skin. ... - Newsday,

DUSA Pharmaceuticals, Inc. to Present at UBS Global Life Sciences ... Sep 21, 2005
...is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple ... - PharmaLive.com (press release),

Business briefs Sep 23, 2005
The source, which emits between 400 - 800 nm, has been approved for use with a variety of drugs including 5-ALA, Foscan and Levulan. ... - Optics.org,

Dusa Announces Second Quarter 2005 Levulan'R' Kerastick'R' And BLU ... Jul 14, 2005
Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) today announced second quarter (Q2) Levulan(R) Kerastick(R) and BLU-U(R) end-user sales. For ... - Business Wire (press release)

DUSA Pharmaceuticals Reports Second Quarter Financial Results Aug 3, 2005
Second quarter 2005 end-user Levulan(R) Kerastick(R) net sales to physicians totaled 20,172 Kerastick units, versus 17,910 in the second quarter of 2004. ... - Business Wire (press release)

DUSA Pharmaceuticals, Inc. To Host Second Quarter 2005 Corporate ... Jul 29, 2005
...is a biopharmaceutical company engaged primarily in the development of Levulan(R) Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical ... - Business Wire (press release)

DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second ... Jul 12, 2005
...(NASDAQ NMS:DUSA) announces that an update regarding second quarter Levulan Kerastick and BLU-U end user sales will be issued after the close on Thursday July ... - PharmaLive.com (press release)

Health Stocks in Motion Jul 15, 2005
...the second quarter sales results, we continue to receive very positive feedback about our therapy from doctors across the country that believe Levulan PDT will ... - TheStreet.com

DUSA Announces Resignation of Officer Jul 14, 2005
...is a biopharmaceutical company engaged primarily in the development of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical ... - Business Wire (press release)

Tom Wheeler to Keynote Cosmetic Boot Camp Jul 15, 2005
...focus on integrating StarLux for a successful aesthetic practice for photorejuvenation, leg vein treatments, combination therapy with Levulan/Botulinum Toxin A ... - Yahoo News (press release) <**results**>

DUSA Provides Investor Update Jun 22, 2005
June 22, 2005) - In response to current market conditions, DUSA Pharmaceuticals (NASDAQ NMS:DUSA) reports that it now expects sales of its Levulan(R) Kerastick ... - CCNMatthews (press release)

DUSA Provides Investor Update Jun 22, 2005
In response to current market conditions, DUSA Pharmaceuticals (NASDAQ NMS:DUSA) reports that it now expects sales of its Levulan(R) Kerastick(R) and BLU-U(R ... - Genetic Engineering News

DUSA Provides Investor Update Jun 23, 2005
WILMINGTON -- In response to current market conditions, DUSA Pharmaceuticals (NASDAQ NMS:DUSA) reports that it now expects sales of its Levulan(R) Kerastick(R ... - dBusinessNews Boston (press release),